John J. Baldwin serves as Executive at GLYCOMIMETICS INC, where they oversee executive responsibilities. Since joining the company, John J. Baldwin has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 29, 2016 involved exercising options for 605 shares valued at $678.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jun 29, 2016 | GLYC | $678 | Option Exercise | 605 | $1.12 | Discretionary |
John J. Baldwin currently holds 1,210 shares of GLYCOMIMETICS INC (GLYC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John J. Baldwin has been a net neutral trader of GLYC stock. They have purchased $0 and sold $0 worth of shares.
John J. Baldwin's most recent insider trade was on Jun 29, 2016, when they sold 605 shares at $1.12 per share.
Get notified when new Form 4 filings are submitted